- Report
- October 2022
- 220 Pages
Global
From €1812EUR$1,899USD£1,519GBP
- Report
- June 2023
- 56 Pages
Global
€2338EUR$2,450USD£1,959GBP
- Report
- December 2022
- 56 Pages
China
€1522EUR$1,595USD£1,275GBP
- Report
- January 2022
- 242 Pages
Global
From €4580EUR$4,799USD£3,837GBP
- Report
- November 2023
- 312 Pages
Global
From €5374EUR$5,827USD£4,350GBP
- Report
- April 2023
- 353 Pages
Global
From €4879EUR$5,292USD£3,950GBP
- Report
- December 2022
- 261 Pages
Global
From €4879EUR$5,292USD£3,950GBP
- Report
- March 2023
- 71 Pages
Global
From €480EUR$539USD£416GBP
- Report
- March 2023
- 185 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Report
- January 2022
- 120 Pages
Global
€4629EUR$4,850USD£3,878GBP
- Report
- January 2024
- 253 Pages
Global
From €4438EUR$4,650USD£3,718GBP
- Report
- February 2023
- 123 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Report
- May 2022
- 335 Pages
Global
From €5249EUR$5,500USD£4,398GBP
- Report
- August 2021
- 159 Pages
Global
From €2625EUR$2,750USD£2,199GBP
€5249EUR$5,500USD£4,398GBP
- Report
- February 2024
- 408 Pages
Global
From €4724EUR$4,950USD£3,958GBP
- Report
- July 2023
- 80 Pages
Global
From €4629EUR$4,850USD£3,878GBP
- Report
- November 2023
- 165 Pages
Global
From €2362EUR$2,475USD£1,979GBP
€4724EUR$4,950USD£3,958GBP
- Report
- December 2023
- 153 Pages
Global
From €2362EUR$2,475USD£1,979GBP
€4724EUR$4,950USD£3,958GBP
- Report
- December 2023
- 155 Pages
Global
From €2362EUR$2,475USD£1,979GBP
€4724EUR$4,950USD£3,958GBP
- Report
- June 2020
- 148 Pages
Global
From €4724EUR$4,950USD£3,958GBP

The Protein Drugs market is a subset of the larger Drug Discovery industry. It focuses on the development of drugs that are based on proteins, such as monoclonal antibodies, cytokines, and growth factors. These drugs are used to treat a variety of diseases, including cancer, autoimmune disorders, and infectious diseases. Protein drugs are typically developed through recombinant DNA technology, which involves the manipulation of genetic material to create a desired protein.
The Protein Drugs market is highly competitive, with many companies vying for a share of the market. Companies in the market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are engaged in research and development of new protein drugs, as well as the marketing and distribution of existing drugs. Show Less Read more